EP3532606A4 - Immunsuppressive mesenchymale zellen und verfahren zur herstellung davon - Google Patents
Immunsuppressive mesenchymale zellen und verfahren zur herstellung davon Download PDFInfo
- Publication number
- EP3532606A4 EP3532606A4 EP17866094.0A EP17866094A EP3532606A4 EP 3532606 A4 EP3532606 A4 EP 3532606A4 EP 17866094 A EP17866094 A EP 17866094A EP 3532606 A4 EP3532606 A4 EP 3532606A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- mesenchymal cells
- forming same
- immunosuppressive mesenchymal
- immunosuppressive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000001506 immunosuppresive effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/231—Interleukin-10 (IL-10)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662413696P | 2016-10-27 | 2016-10-27 | |
US201762530617P | 2017-07-10 | 2017-07-10 | |
PCT/US2017/058686 WO2018081514A1 (en) | 2016-10-27 | 2017-10-27 | Immunosuppressive mesenchymal cells and methods for forming same |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3532606A1 EP3532606A1 (de) | 2019-09-04 |
EP3532606A4 true EP3532606A4 (de) | 2020-07-29 |
Family
ID=62025493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17866094.0A Withdrawn EP3532606A4 (de) | 2016-10-27 | 2017-10-27 | Immunsuppressive mesenchymale zellen und verfahren zur herstellung davon |
Country Status (9)
Country | Link |
---|---|
US (1) | US20190314417A1 (de) |
EP (1) | EP3532606A4 (de) |
JP (1) | JP2019534015A (de) |
KR (1) | KR20190085000A (de) |
CN (1) | CN110121553A (de) |
AU (1) | AU2017348306A1 (de) |
CA (1) | CA3042031A1 (de) |
IL (1) | IL266251A (de) |
WO (1) | WO2018081514A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020086687A1 (en) * | 2018-10-23 | 2020-04-30 | The Johns Hopkins University | Partioning of adult mesenchymal stem cells |
TW202035682A (zh) | 2018-12-14 | 2020-10-01 | 比利時商普羅米修亞生物科技股份有限公司 | 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途 |
JP2022513475A (ja) | 2018-12-14 | 2022-02-08 | プロメセラ セラピューティクス エスエイ | Hla-eを発現する肝臓前駆細胞を含む細胞組成物 |
KR102331880B1 (ko) * | 2019-01-29 | 2021-11-29 | 연세대학교 산학협력단 | 엑소좀을 추출하는 방법 및 이에 이용되는 조성물 |
US20220062347A1 (en) * | 2019-03-08 | 2022-03-03 | Niigata University | Induction method for macrophage, anti-inflammatory macrophage-inducing agent, and pharmaceutical composition |
KR102503349B1 (ko) | 2019-05-14 | 2023-02-23 | 프로벤션 바이오, 인코포레이티드 | 제1형 당뇨병을 예방하기 위한 방법 및 조성물 |
WO2021009778A2 (en) * | 2019-07-18 | 2021-01-21 | Pandorum Technologies Private Limited | Methods for culturing mesenchymal stem cells, products thereof, and applications thereof |
WO2022221672A1 (en) * | 2021-04-16 | 2022-10-20 | Ossium Health, Inc. | Interferon gamma-primed mesenchymal stromal cells as prophylaxis for graft versus host disease |
KR20240054991A (ko) * | 2021-08-11 | 2024-04-26 | 판도럼 테크놀로지스 프라이뱃 리미티드 | 중간엽 줄기 세포의 배양 방법, 그의 조성물 및 구현 |
CN114438022A (zh) * | 2021-12-03 | 2022-05-06 | 睿仕康(重庆)生物科技有限公司 | 具有免疫抑制、抗炎功能的间充质干细胞、其制备方法及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014093948A1 (en) * | 2012-12-14 | 2014-06-19 | Rutgers, The State University Of New Jersey | Methods modulating immunoregulatory effect of stem cells |
WO2016053758A1 (en) * | 2014-10-01 | 2016-04-07 | Commence Bio, Inc. | Induction medium and methods for stem cell culture and therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8709401B2 (en) * | 2011-02-25 | 2014-04-29 | Howmedica Osteonics Corp. | Primed stem cells and uses thereof to treat inflammatory conditions in joints |
US20160237407A1 (en) * | 2015-02-17 | 2016-08-18 | Batu Biologics, Inc. | Universal donor chimeric antigen receptor cells |
-
2017
- 2017-10-27 JP JP2019523573A patent/JP2019534015A/ja active Pending
- 2017-10-27 CA CA3042031A patent/CA3042031A1/en active Pending
- 2017-10-27 AU AU2017348306A patent/AU2017348306A1/en not_active Abandoned
- 2017-10-27 KR KR1020197015199A patent/KR20190085000A/ko not_active Application Discontinuation
- 2017-10-27 WO PCT/US2017/058686 patent/WO2018081514A1/en active Application Filing
- 2017-10-27 EP EP17866094.0A patent/EP3532606A4/de not_active Withdrawn
- 2017-10-27 CN CN201780080863.6A patent/CN110121553A/zh active Pending
-
2019
- 2019-04-26 US US16/395,995 patent/US20190314417A1/en active Pending
- 2019-04-28 IL IL266251A patent/IL266251A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014093948A1 (en) * | 2012-12-14 | 2014-06-19 | Rutgers, The State University Of New Jersey | Methods modulating immunoregulatory effect of stem cells |
WO2016053758A1 (en) * | 2014-10-01 | 2016-04-07 | Commence Bio, Inc. | Induction medium and methods for stem cell culture and therapy |
Non-Patent Citations (10)
Title |
---|
BURON F ET AL: "Human Mesenchymal Stem Cells and Immunosuppressive Drug Interactions in Allogeneic Responses: An In Vitro Study Using Human Cells", TRANSPLANTATION PROCEEDINGS, ELSEVIER INC, ORLANDO, FL; US, vol. 41, no. 8, 1 October 2009 (2009-10-01), pages 3347 - 3352, XP026708145, ISSN: 0041-1345, [retrieved on 20091023], DOI: 10.1016/J.TRANSPROCEED.2009.08.030 * |
EUN-SOL LEE ET AL: "Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model", PLOS ONE, vol. 10, no. 9, 22 September 2015 (2015-09-22), pages e0138846, XP055700317, DOI: 10.1371/journal.pone.0138846 * |
HOLLY M. WOBMA ET AL: "Dual IFN-[gamma]/hypoxia priming enhances immunosuppression of mesenchymal stromal cells through regulatory proteins and metabolic mechanisms", JOURNAL OF IMMUNOLOGY AND REGENERATIVE MEDICINE, vol. 1, 1 March 2018 (2018-03-01), pages 45 - 56, XP055698674, ISSN: 2468-4988, DOI: 10.1016/j.regen.2018.01.001 * |
HOLLY MICHELLE WOBMA: "Interferon-gamma/Hypoxia Primed Mesenchymal Stem Cells for an Improved Immunosuppressive Cell Therapy", 1 January 2018 (2018-01-01), XP055698676, Retrieved from the Internet <URL:https://academiccommons.columbia.edu/doi/10.7916/D8ZC9K1D> DOI: 10.7916/D8ZC9K1D * |
HONG-CHAO ZHANG ET AL: "Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Stimulated by Hypoxia Promote Angiogenesis Both In Vitro and In Vivo", STEM CELLS AND DEVELOPMENT, vol. 21, no. 18, 10 December 2012 (2012-12-10), pages 3289 - 3297, XP055173734, ISSN: 1547-3287, DOI: 10.1089/scd.2012.0095 * |
MOSTAFA EJTEHADIFAR ET AL: "The Effect of Hypoxia on Mesenchymal Stem Cell Biology", ADVANCED PHARMACEUTICAL BULLETIN, vol. 5, no. 2, 1 June 2015 (2015-06-01), pages 141 - 149, XP055698678, ISSN: 2228-5881, DOI: 10.15171/apb.2015.021 * |
MYOUNG WOO LEE ET AL: "Strategies to improve the immunosuppressive properties of human mesenchymal stem cells", STEM CELL RESEARCH & THERAPY, BIOMED CENTRAL LTD, LONDON, UK, vol. 6, no. 1, 7 October 2015 (2015-10-07), pages 179, XP021229541, ISSN: 1757-6512, DOI: 10.1186/S13287-015-0178-Y * |
NAZMUL HAQUE ET AL: "Hypoxic Culture Conditions as a Solution for Mesenchymal Stem Cell Based Regenerative Therapy", THE SCIENTIFIC WORLD JOURNAL, vol. 2013, 1 January 2013 (2013-01-01), pages 1 - 12, XP055567038, DOI: 10.1155/2013/632972 * |
See also references of WO2018081514A1 * |
YAHAIRA NAALDIJK ET AL: "Migrational changes of mesenchymal stem cells in response to cytokines, growth factors, hypoxia, and aging", EXPERIMENTAL CELL RESEARCH, vol. 338, no. 1, 1 October 2015 (2015-10-01), AMSTERDAM, NL, pages 97 - 104, XP055698677, ISSN: 0014-4827, DOI: 10.1016/j.yexcr.2015.08.019 * |
Also Published As
Publication number | Publication date |
---|---|
IL266251A (en) | 2019-06-30 |
AU2017348306A1 (en) | 2019-05-23 |
WO2018081514A1 (en) | 2018-05-03 |
US20190314417A1 (en) | 2019-10-17 |
CN110121553A (zh) | 2019-08-13 |
EP3532606A1 (de) | 2019-09-04 |
JP2019534015A (ja) | 2019-11-28 |
KR20190085000A (ko) | 2019-07-17 |
CA3042031A1 (en) | 2018-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3523419A4 (de) | Zusammensetzungen und verfahren zur bewahrung der lebensfähigkeit von zellen | |
EP3532606A4 (de) | Immunsuppressive mesenchymale zellen und verfahren zur herstellung davon | |
EP3430407A4 (de) | Zusammensetzungen, vorrichtungen und verfahren zur zelltrennung | |
EP3273976A4 (de) | Modifizierte t-zellen und verfahren zur herstellung und verwendung davon | |
EP3205720A4 (de) | Car-expressions-vektor und car-exprimierende t-zellen | |
EP3612568B8 (de) | Zelle | |
EP3522263A4 (de) | Sekundärbatterie | |
EP3455344A4 (de) | Hämatopoetische stamm-/vorläuferzellen | |
EP3245303A4 (de) | Altersmodifizierte zellen und verfahren zur herstellung altersmodifizierter zellen | |
EP3410524A4 (de) | Festoxidbrennstoffzelle | |
EP3105315A4 (de) | Kits und verfahren zur neuprogrammierung von nichthepatozytenzellen in hepatozytenzellen | |
EP3278388A4 (de) | Festkörperbatteriezellen und verfahren zur herstellung davon | |
EP3252141A4 (de) | Zellkulturverfahren und kit | |
EP3436035A4 (de) | Zusammensetzungen und verfahren zur verwendung kleiner mobiler stammzellen | |
EP3537511A4 (de) | Elektrode für eine zelle und zelle | |
EP3383182A4 (de) | Verfahren zur erzeugung funktioneller hämatopoetischer stammzellen | |
EP3299023A4 (de) | Sauerstoffarm behandelte mesenchymale stammzelle und deren verwendung | |
EP3107996A4 (de) | Tscm-zellen und verfahren zur verwendung | |
EP3365107B8 (de) | Zellkultur | |
EP3419617A4 (de) | Hochgradig transplantierbare hämatopoetische stammzellen | |
EP3534431A4 (de) | Separator für eine batterie mit wasserfreiem elektrolyt sowie batterie mit wasserfreiem elektrolyt | |
EP3464565A4 (de) | Zellexpansion | |
EP3243902A4 (de) | Luterion und trennung und kultivierungsverfahren dafür | |
EP3452500A4 (de) | Proliferation von mesenchymalen stammzellen | |
EP3413385A4 (de) | Brennstoffzelle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190522 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200625 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 35/545 20150101ALI20200619BHEP Ipc: A61K 35/28 20150101ALI20200619BHEP Ipc: C12N 5/0775 20100101AFI20200619BHEP |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40014543 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20210126 |